The GSK saxon Serum plant produces flu vaccination substances for the world market, with a yearly production of aprox. 30 million of doses. 94.3 million € was the investment amount destinated to built the plant. For the flu campaigne 2008/2009 GSK will be able to duplicate its production.
| Project type: | Pharmaceutical production plant for vaccines |
| Location: | Germany (Dresden) |
| Investment amount: | 94.3 Mio. EUR |
| Investor: | GlaxoSmithKline GmbH & Co.KG |
| Time period: | 01.05.2006 – 30.04.2007 |
| Performance: | Time scheduling, planning and control of resources |
Time scheduling of structure work, building and process technics as well as scheduling and control of resources during the planning and execution time.
